US Stock MarketDetailed Quotes

Cardiac Biotech Solutions (CBSC)

Watchlist
  • 0.0300
  • 0.00000.00%
15min DelayClose Jul 20 15:59 ET
4.96MMarket Cap-3.00P/E (TTM)

Cardiac Biotech Solutions (CBSC) Cash Flow

Quarterly·All
YOY yoy
Hide blank lines yoy
Currency: USD
2026/Q1
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
2023/Q3
2023/Q2
2023/Q1
2022/Q4
2022/Q3
2022/Q2
2022/Q1
Operating Cash Flow
+12.54%-141.07K
+50.50%-181.49K
+34.61%-161.29K
-311.30%-508.17K
+57.48%-123.94K
+11.13%-366.63K
+31.37%-246.68K
+44.23%-123.55K
-0.64%-291.46K
-222.77%-412.55K
-144.39%-359.44K
---221.53K
---289.61K
---127.82K
---147.08K
Net cash flow from continuing operations
+12.54%-141.07K
+50.50%-181.49K
+34.61%-161.29K
-311.30%-508.17K
+57.48%-123.94K
+11.13%-366.63K
+31.37%-246.68K
+44.23%-123.55K
-0.64%-291.46K
-222.77%-412.55K
-144.39%-359.44K
---221.53K
---289.61K
---127.82K
---147.08K
Net Income from Continuing Operations
+27.86%-190.74K
+30.40%-341.89K
+17.41%-264.41K
+56.52%-331.88K
-13.47%-487.03K
-9.50%-491.20K
+31.23%-320.13K
+48.23%-763.28K
+89.28%-429.21K
-14.18%-448.58K
+1.35%-465.51K
---1.47M
---4.00M
---392.88K
---471.90K
Gain/Loss from Continuing Operations
---96.38K
----
----
--0.00
--0.00
----
----
----
----
----
----
--2.91M
----
----
----
Depreciation & Depletion & Amortization
----
----
----
----
----
----
----
----
----
----
----
--0.00
--67.00
--154.00
--390.00
Other Non-Cash Items
+1432.64%68.97K
--5.67K
--4.50K
----
----
----
----
+110.61%171.09K
-97.51%87.07K
-86.61%25.21K
-74.46%60.93K
---1.61M
--3.49M
--188.30K
--238.57K
Change in Working Capital
-21.84%77.08K
+101.49%192.06K
+54.93%98.62K
-145.55%-176.29K
+616.54%363.09K
+929.82%95.32K
+95.49%63.66K
+538.85%387.02K
-63.17%50.67K
-77.76%9.26K
-62.07%32.56K
---88.19K
--137.59K
--41.61K
--85.86K
-Change in Receivables
-1264.45%-35.65K
-1111.18%-1.63K
-173.52%-2.61K
-465.43%-2.07K
---2.48K
-93.17%161.00
-92.07%3.55K
+101.12%567.00
--0.00
+139.10%2.36K
+1215.94%44.81K
---50.57K
--0.00
---6.03K
---4.02K
-Change in Inventory
----
----
----
+80.76%-4.50K
----
----
----
-212.94%-23.39K
+100.00%0.00
-100.00%0.00
+2611.11%9.27K
--20.71K
---342.00
--342.00
--342.00
-Change in Prepaid Assets
-50.00%1.88K
+1341.33%54.05K
+0.00%3.75K
-163.21%-11.85K
+113.78%3.75K
-42.54%3.75K
+128.73%3.75K
+107.46%18.75K
-109.05%-27.22K
+112.83%6.53K
---13.05K
---251.15K
--300.86K
---50.86K
--0.00
-Change in Payables and Accrued Expense
+12.44%120.83K
+47.52%149.72K
-24.52%107.46K
-1890.54%-147.90K
+377.28%371.90K
+29232.66%101.49K
+1782.72%142.38K
-103.85%-7.43K
+147.82%77.92K
-99.64%346.00
-109.36%-8.46K
--192.82K
---162.93K
--97.29K
--90.39K
-Change in Other Current Liabilities
----
----
----
----
----
----
----
----
----
----
----
----
----
----
---859.00
-Change In Other Working Capital
+0.00%-9.97K
+0.00%-10.08K
+88.41%-9.97K
---9.97K
---10.08K
---10.08K
---86.02K
----
----
----
----
----
----
----
----
Net cash flow from investing
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
-100.00%0.00
+100.00%0.00
--0.00
--0.00
--40.00K
---40.00K
--0.00
--0.00
--0.00
Net Cash Flow from Continuing Investing Activities
----
--0.00
--0.00
--0.00
--0.00
--0.00
-100.00%0.00
+100.00%0.00
--0.00
--0.00
--40.00K
---40.00K
--0.00
--0.00
--0.00
Net Other Investing Changes
----
----
----
----
----
----
----
--0.00
--0.00
--0.00
--40.00K
----
----
----
----
Financing Cash Flow
+145.76%113.05K
-5.30%326.72K
-65.93%46.00K
+59.06%400.00K
+136.67%355.00K
-24.18%345.00K
--135.00K
+3404.52%251.48K
-82.75%150.00K
+136.08%455.00K
-100.00%0.00
--7.18K
--869.43K
--192.73K
--164.95K
Net Cash Flow from Continuing Financing Activities
+145.76%113.05K
-5.30%326.72K
-65.93%46.00K
+59.06%400.00K
+136.67%355.00K
-24.18%345.00K
--135.00K
+3404.52%251.48K
-82.75%150.00K
+136.08%455.00K
-100.00%0.00
--7.18K
--869.43K
--192.73K
--164.95K
Net Issuance Payments Of Debt
+240.00%85.00K
--285.00K
--25.00K
--0.00
-100.00%0.00
--0.00
--0.00
-100.00%0.00
-82.75%150.00K
----
----
--1.24K
--869.43K
--192.73K
--164.95K
Net Common Stock Issuance
+33.57%28.05K
-87.91%41.72K
-84.44%21.00K
+60.00%400.00K
--355.00K
--345.00K
--135.00K
--250.00K
--0.00
--0.00
--0.00
----
----
----
----
Ending Cash Balance
+104.64%21.99K
+4853.16%155.98K
-56.63%10.75K
-7.64%126.04K
+2646.68%234.21K
-97.90%3.15K
-76.96%24.78K
-68.04%136.46K
-98.75%8.53K
+47.77%149.99K
+193.93%107.54K
--426.98K
--681.33K
--101.50K
--36.59K
Net Change in Cash
+75.70%-28.02K
+771.36%145.23K
-3.24%-115.29K
-184.55%-108.17K
+263.33%231.06K
-150.95%-21.63K
+65.04%-111.68K
+150.30%127.93K
-124.40%-141.46K
-34.60%42.46K
-1887.38%-319.44K
---254.35K
--579.82K
--64.92K
--17.87K
Beginning Cash Balance
-60.32%50.01K
-56.63%10.75K
-7.64%126.04K
+2646.68%234.21K
-97.90%3.15K
-76.96%24.78K
-68.04%136.46K
-98.75%8.53K
+47.77%149.99K
+193.93%107.54K
+2181.71%426.98K
--681.33K
--101.50K
--36.59K
--18.71K
Free Cash Flow
+12.54%-141.07K
+50.50%-181.49K
+34.61%-161.29K
-311.30%-508.17K
+57.48%-123.94K
+11.13%-366.63K
+31.37%-246.68K
+44.23%-123.55K
-0.64%-291.46K
-222.77%-412.55K
-144.39%-359.44K
---221.53K
---289.61K
---127.82K
---147.08K
Deadline
Jun 30, 2025
Sep 30, 2024
Jun 30, 2024
Mar 31, 2024
Dec 31, 2023
Sep 30, 2023
Jun 30, 2023
Mar 31, 2023
Dec 31, 2022
Sep 30, 2022
Jun 30, 2022
Mar 31, 2022
Dec 31, 2021
Sep 30, 2021
Jun 30, 2021
Accounting Standard
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
2026/Q12025/Q22025/Q12024/Q42024/Q32024/Q22024/Q12023/Q42023/Q32023/Q22023/Q12022/Q42022/Q32022/Q22022/Q1
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Latest: Citing a senior Iranian official, foreign media reported on the 20th that intermediaries in Iran-U.S. negotiations have presented Te Show More